B
Barbara A. Brown-Elliott
Researcher at University of Texas Health Science Center at Tyler
Publications - 114
Citations - 14513
Barbara A. Brown-Elliott is an academic researcher from University of Texas Health Science Center at Tyler. The author has contributed to research in topics: Nontuberculous mycobacteria & Mycobacterium abscessus. The author has an hindex of 45, co-authored 105 publications receiving 12771 citations. Previous affiliations of Barbara A. Brown-Elliott include University of Texas at Austin.
Papers
More filters
Journal ArticleDOI
An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.
David E. Griffith,Timothy R. Aksamit,Barbara A. Brown-Elliott,Antonino Catanzaro,Charles L. Daley,Fred M. Gordin,Steven M. Holland,Robert Horsburgh,Gwen A. Huitt,Michael F. Iademarco,Michael D. Iseman,Kenneth N. Olivier,Stephen J. Ruoss,C. Fordham von Reyn,Richard J. Wallace,Kevin L. Winthrop +15 more
TL;DR: Diagnostic Criteria of Nontuberculous Mycobacterial Lung Disease Key Laboratory Features of N TM Health Careand Hygiene-associated Disease Prevention Prophylaxis and Treatment of NTM Disease Introduction Methods.
Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes
Gail L. Woods,Barbara A. Brown-Elliott,Patricia S. Conville,Edward Desmond,Geraldine S. Hall,Grace Lin,Gaby E. Pfyffer,John C. Ridderhof,Salman H. Siddiqi,Richard J. Wallace,Nancy G. Warren,Frank G. Witebsky +11 more
TL;DR: This standard includes susceptibility testing procedures for Mycobacterium tuberculosis complex (MTBC), clinically significant slowly and rapidly growing mycobacterial species, Nocardia spp.
Journal ArticleDOI
Clinical and Laboratory Features of the Nocardia spp. Based on Current Molecular Taxonomy
TL;DR: This review characterizes the currently known pathogenic species of Nocardia, including clinical disease, drug susceptibility, and methods of identification, including PCR restriction enzyme analysis and 16S rRNA sequencing.
Journal ArticleDOI
Clinical and Taxonomic Status of Pathogenic Nonpigmented or Late-Pigmenting Rapidly Growing Mycobacteria
TL;DR: The history, taxonomy, geographic distribution, clinical disease, and therapy of the pathogenic nonpigmented or late-pigmenting rapidly growing mycobacteria (RGM) are reviewed and laboratory diagnosis of RGM using phenotypic methods such as biochemical testing and high-performance liquid chromatography and molecular methods of diagnosis are discussed.
Journal ArticleDOI
Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.
TL;DR: This article reviews the laboratory, diagnostic, and treatment guidelines together with established and probable drug resistance mechanisms of the nontuberculous mycobacteria.